Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01153464 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study

A Phase 2 study, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 2
Development phase
200
Enrollment target

NCT01153464: Completed Phase 2 study, sponsored by University of Pennsylvania.

NCT01153464 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01153464, a Phase 2 study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 2
Development phase
200 participants
Enrollment target

Study Summary

This protocol (a supplement to 805466) is to test whether our telephone continuing care model can be implemented successfully by "real world" publicly funded programs. Participants will be recruited from Philadelphia's Department of Behavioral Health - run drug programs. The investigators will train city telephone care managers to deliver our telephone continuing care intervention to patients in this program. The investigators will randomize 200 to receive this intervention or usual care and follow them for 12 months.

Interventions

  • BEHAVIORAL Recovery Support Counseling

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2009-10
Est. Completion 2011-09
Phase Phase 2

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01153464

The ClinicalTrials.gov registry entry for NCT01153464 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Recovery Support Counseling is the first listed.

NCT01153464 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01153464 about?

NCT01153464 is a clinical study titled "Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study". This protocol (a supplement to 805466) is to test whether our telephone continuing care model can be implemented successfully by "real world" publicly funded programs. Participants will be recruited from Philadelphia's Department of Behavioral Health - run drug programs. The investigators will train...

What is the current status of trial NCT01153464?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2009-10. Estimated completion is 2011-09.

What interventions are being tested in trial NCT01153464?

The interventions under investigation include: Recovery Support Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01153464?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.